News

Celebrated, then disparaged: mRNA’s promise is tarnished under Trump
The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...
Vaxart, Inc.: Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
Vaxart, Inc. (Nasdaq: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral recombinant pill ...
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today ...